Comparison of the clinicopathological characteristics and the survival outcomes between the Siewert type II/III adenocarcinomas

详细信息    查看全文

• 作者：Wei-Han Zhang (1)
  Xin-Zu Chen (1)
  Kai Liu (1)
  Kumar Anil (1)
  Kun Yang (1)
  Jia-Ping Chen (1)
  Zong-Guang Zhou (1)
  Jian-Kun Hu (1)
  
• 关键词：Siewert classification ; Gastrectomy ; Survival ; Adenocarcinomas of esophagogastric junction
• 刊名：Medical Oncology
• 出版年：2014
• 出版时间：August 2014
• 年：2014
• 卷：31
• 期：8
• 全文大小：337 KB
• 参考文献：1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-08. CrossRef
  2. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of espohageal and gastric carcinoma in the United States. Cancer. 1998;83:2049-3. CrossRef
  3. Okabayashi T, Gotoda T, Kondo H, et al. Early carcinoma of the gastric cardia in Japan: is it different from that in the West? Cancer. 2000;89(12):2555-. CrossRef
  4. Salvon-Harman JC, Cady B, Nikulasson S, et al. Shifting proportions of gastric adenocarcinomas. Arch Surg. 1994;129(4):381-. CrossRef
  5. Stein HJ, Feith M, Siewert JR. Cancer of the esophagogastric junction. Surg Oncol. 2000;9(1):35-1. CrossRef
  6. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85(11):1457-. CrossRef
  7. Rüdiger Siewert J, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg. 2000;232(3):353-1. CrossRef
  8. Kodera Y, Yamamura Y, Shimizu Y, et al. Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert’s classification applied to 177 cases resected at a single institution. J Am Coll Surg. 1999;189(6):594-01. CrossRef
  9. von Rahden BH, Stein HJ, Siewert JR. Surgical management of esophagogastric junction tumors. World J Gastroenterol. 2006;12(41):6608-3.
  10. Sasako M, Sano T, Yamamoto S, et al. Japan Clinical Oncology Group (JCOG9502). Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol. 2006;7(8):644-1. CrossRef
  11. Kim KT, Jeong O, Jung MR, et al. Outcomes of abdominal total gastrectomy for type II and III gastroesophageal junction tumors: single center’s experience in Korea. J Gastric Cancer. 2012;12(1):36-2. CrossRef
  12. Zhang H, Wang W, Cheng Y, et al. Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China. World J Surg Oncol. 2013;11:155. CrossRef
  13. Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246(6):992-000 discussion 1000-001. CrossRef
  14. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347(21):1662-. CrossRef
  15. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-nd English edition. Gastric Cancer. 1998;1:10-4. CrossRef
  16. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101-2. CrossRef
  17. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265(10):1287-. CrossRef
  18. Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev. 2010;19(6):1468-0. CrossRef
  19. Fang WL, Wu CW, Chen JH, et al. Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan. Ann Surg Oncol. 2009;16(12):3237-4. CrossRef
  20. Hasegawa S, Yoshikawa T, Cho H, et al. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center. World J Surg. 2009;33(1):95-03. CrossRef
  21. Kodama I, Kofuji K, Yano S, et al. Lymph node metastasis and lymphadenectomy for carcinoma in the gastric cardia: clinical experience. Int Surg. 1998;83(3):205-.
  22. Suttie SA, Li AG, Quinn M, et al. The impact of operative approach on outcome of surgery for gastro-oesophageal tumours. World J Surg Oncol. 2007;5:95. CrossRef
  23. Yang K, Chen HN, Chen XZ, et al. Transthoracic resection versus non-transthoracic resection for gastroesophageal junction cancer: a meta-analysis. PLoS One. 2012;7(6):e37698. CrossRef
  24. Chou SH, Chuang HY, Huang MF, et al. A prospective comparison of transthoracic and transhiatal resection for esophageal carcinoma in Asians. Hepatogastroenterology. 2009;56(91-2):707-0.
  25. Husemann B. Cardia carcinoma considered as a distinct clinical entity. Br J Surg. 1989;76(2):136-. CrossRef
  26. Yonemura Y, Tsugawa K, Fonseca L, et al. Lymph node metastasis and surgical management of gastric cancer invading the esophagus. Hepatogastroenterology. 1995;42(1):37-2.
  27. Dresner SM, Lamb PJ, Bennett MK, et al. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery. 2001;129(1):103-. CrossRef
  28. Kawaura Y, Mori Y, Nakajima H, Iwa T. Total gastrectomy with left oblique abdominothoracic approach for gastric cancer involving the esophagus. Arch Surg. 1988;123(4):514-. CrossRef
  29. Nakamura M, Iwahashi M, Nakamori M, et al. Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinomas in the gastroesophageal junction. Am Surg. 2012;78(5):567-3.
  30. Hosokawa Y, Kinoshita T, Konishi M, et al. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Ann Surg Oncol. 2012;19(2):677-3. CrossRef
  31. Kawaguchi T, Komatsu S, Ichikawa D, et al. Comparison of prognostic compatibility between seventh AJCC/TNM of the esophagus and 14th JCGC staging systems in Siewert type II adenocarcinoma. Anticancer Res. 2013;33(8):3461-.
  32. Suh YS, Han DS, Kong SH, et al. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification. Ann Surg. 2012;255(5):908-5. CrossRef
  33. Gertler R, Stein HJ, Loos M, et al. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer? Am J Surg Pathol. 2011;35(10):1512-2. CrossRef
  
• 作者单位：Wei-Han Zhang (1)
  Xin-Zu Chen (1)
  Kai Liu (1)
  Kumar Anil (1)
  Kun Yang (1)
  Jia-Ping Chen (1)
  Zong-Guang Zhou (1)
  Jian-Kun Hu (1)
  
  1. Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang Street, Chengdu, 610041, Sichuan Province, China
  
• ISSN：1559-131X

文摘

The aim of the study was to analyze the clinicopathological characteristics and survival outcomes in Siewert type II and Siewert type III tumors. The clinicopathological characteristics and survival outcomes were analyzed in patients diagnosed with Siewert II/III tumors, who underwent transabdominal gastrectomy from Jan 2006 to Dec 2010. A total of 321 patients diagnosed with Siewert II/III tumors who underwent gastrectomy were enrolled in this study. Siewert III tumors are larger and have a higher proportion of Borrmann 3- types than Siewert II tumors (p?